Associations among S100A4, Sphingosine-1-Phosphate, and Pulmonary Function in Patients with Chronic Obstructive Pulmonary Disease

Abstract

Background. S100A4 is a member of the S100 calcium-binding protein family and is increased in patients with chronic obstructive pulmonary disease (COPD). Sphingosine-1-phosphate (S1P) is a naturally occurring bioactive sphingolipid, which regulates the adhesion between the cells and the extracellular matrix and affects cell migration and differentiation. The goal of this study was to analyze the correlations among S100A4, S1P, and pulmonary function among COPD patients. Methods. All 139 serum samples and 15 lung specimens were collected in COPD patients and control subjects. S100A4 and S1P were detected in two groups. The markers of fibrosis and epithelial-mesenchymal transition (EMT) were measured in the lungs of COPD patients and control subjects. Results. The protein expression of S100A4 was higher in the lungs and serum of COPD patients than control cases. Additionally, serum S100A4 was inversely associated with pulmonary function among COPD patients. Meanwhile, collagen deposition and EMT nuclear transcription factors were elevated in the lungs of COPD patients. Moreover, the protein expression of S1P was increased in the serum of COPD patients. Serum S1P was gradually increased along with pulmonary function decline in COPD patients. Further correlation analysis revealed that serum S1P was negatively associated with pulmonary function in COPD patients. Furthermore, there was a positive correlation between S1P and S100A4 in COPD patients. Conclusions. These results provide evidence that the elevation of S100A4 and S1P may be involved in the onset and progression of COPD.

Endothelial-to-mesenchymal transition: a precursor to pulmonary arterial remodelling in patients with idiopathic pulmonary fibrosis

“…causes lung fibrosis by promoting the proliferation and activation of fibroblast (42)(43)(44) and increased S100A4 elevation has been proposed to contribute in the development of IPF (45)(46)(47)(48). The S100A4 expression was significantly higher in intima layer across all arterial sizes however, we didn't find such a significant expression in media and adventitia layers.…”

Serum TRAIL predicts severity and prognosis in patients with community-acquired pneumonia: a prospective cohort study

“…IL-6 (JYM0140Hu) ELISA kits were obtained from Wuhan ColorfulGene Biological Technology Co ( http://www.jymbio.com/product/316-cn.html ). All ELISA procedures were carried out in accordance with our previous studies with minor adjustments [ 28 – 30 ].…”

The effects of epithelial–mesenchymal transitions in COPD induced by cigarette smoke: an update

“…S100A4 (also named fibroblast specific protein 1, FSP1) is considered a canonical mesenchymal marker in EMT with biological functions of promoting cell motility, invasion, ECM remodeling, autophagy, and angiogenesis [ 80 ]. Numerous studies have demonstrated that S100A4 was upregulated in COPD and inversely associated with airflow limitation [ 67 , 69 , 81 , 82 ]. Vimentin is expressed in all mesenchymal cells and is the core of EMT-mediated metastasis.…”

“…The latest finding showed that serum S1P was upregulated and inversely associated with lung function in patients with COPD. In addition, serum S1P was positively associated with mesenchymal marker S100A4 in COPD [ 81 ]. Cullin 4A (CUL4A), an E3 ubiquitin ligase, is involved in the regulation of the cell cycle, DNA replication, and DNA damage repair [ 94 ].…”